Table 2 Summary disease data
From: Rheumatoid arthritis and sexuality: A patient survey in France
Patients | Controls | |||||
|---|---|---|---|---|---|---|
Sample | Men | Women | Sample | Men | Women | |
Mean (SD), % | Mean (SD), % | Mean (SD), % | Mean (SD), % | Mean (SD), % | Mean (SD), % | |
N | 1268 | 200 | 1068 | 70 | 16 | 54 |
% with disease other than RA | 61.5% | 60% | 62% | 59% | 75% | 53.7% |
Disease duration | 19.0 (11.6) | 16.6 | 19.5 | - | - | - |
HAQ | 1.2 (0.8) | 0.9 | 1.3* | - | - | - |
Disease activity (VAS) | 4.6 (2.2) | 4.1 | 4.7 | - | - | - |
Pain (VAS) | 4.7 (2.2) | 4.2 | 4.7* | - | - | - |
Biologic treatment | 40.8% | 35.4% | 42.2%* | - | - | - |
Global Health (VAS) | 4.5 (1.9) | 4.3 | 4.5 | 3.8 (2.2)** | 3.7 | 3.8 |
Fatigue (VAS) | 5.6 (2.2) | 4.9 | 5.7 | 5.3 (2.4) | 5.1 | 5.5 |
Mood (VAS) | 4.2 (2.2) | 4.0 | 4.2 | 3.9 (2.1) | 4.4 | 3.8 |
Utility | 0.55 (0.3) | 0.61 | 0.54 | 0.65 (0.3)** | 0.57 | 0.68 |